Eventually, our study identified EHD4 and PPARGC1A as key regulators in hepatocellular carcinoma (HCC), particularly through their roles in modulating tumor-associated macrophages (TAMs) and other immune cells within the tumor microenvironment. Here, EHD4 is linked to neoplasm.